FDA approves Eisai breast cancer drug Halaven
November 16, 2010Sales and Marketing Cancer, Eisai, FDA, Halaven, Xeloda, breast cancer, eribulin mesylate, metastatic breast cancer
The FDA has approved Eisai’s advanced breast cancer drug Halaven for use in heavily pre-treated breast cancer patients. Halaven (eribulin …
PolyTherics appoints Dr John Burt chief business officer
November 16, 2010Manufacturing and Production, Research and Development Dr John Burt, PolyTherics, appointment, manufacturing and production, protein engineering, research and development
UK protein engineering company PolyTherics has appointed Dr John Burt as chief business officer. He was previously chief executive of …
Value-based pricing no ‘magic bullet’ – ABPI
November 16, 2010Sales and Marketing ABPI, Dr Richard Barker, NHS drug sales, PPRS, UK medicines pricing, value-based pricing
UK pharma association the ABPI has warned that the government’s planned value-based pricing system for medicines will not necessarily save …
Rising Angel plans manufacturing expansion
November 16, 2010Manufacturing and Production Andrew Carver, Angel Biotechnology, GMP, Good Manufacturing Practice, Pentlands Science Park, Susan McKee, contract manufacturing
Scottish contract manufacturing company Angel Biotechnology plans to increase its capacity by taking over a mothballed production facility after signing …
FDA slaps import ban on Claris Life Sciences
November 16, 2010Manufacturing and Production Ahmedabad, Claris Life Sciences, FDA, GMP, GMP violations, Good Manufacturing Practice, Ranbaxy Pharmaceuticals, manufacturing compliance
Indian drugmaker Claris Life Sciences has been prohibited from importing products into the US after manufacturing quality problems emerged at …
Chiltern Launches “Chiltern Safe”, a Comprehensive Global Trial Master File Management Solution
November 15, 2010Research and Development
“Chiltern SAFE is revolutionizing records management for clinical trials”, stated Sarah Hitching, Chiltern Director, Records Management. “This complete electronic Trial …
Pfizer’s John Proctor moves to Quintiles
November 15, 2010Sales and Marketing John Proctor, Pfizer, Quintiles, UK, appointment, sales and marketing
Quintiles has appointed the former head of Pfizer Health Solutions to lead its own Health Management Solutions (HMS) business. As …
When should pharma leaders trust their gut instinct?
November 15, 2010Business Services, Sales and Marketing decision making, leadership, management
One of the most important questions facing leaders is when they should trust their gut instincts. Our work at McKinsey …
GSK partners with Brazil’s Fiocruz on tropical disease research
November 15, 2010Research and Development Chagas disease, Fiocruz, GSK, GSK’s Tres Cantos Medicines Development Campus, GlaxoSmithKline, Oswald Cruz Foundation, leishmaniasis
GlaxoSmithKline and the Brazil-based Oswald Cruz Foundation (Fiocruz) are to research and develop new medicines for tropical diseases Chagas and …
Quarter of all cancers found at late stage
November 15, 2010Cancer, England, NCIN, NHS, National Cancer Intelligence Network, brain cancer, cancer diagnosis, leukaemia
Nearly a quarter of all cancer diagnoses in England came after a patient had been admitted to hospital for emergency …
Irish cost-effectiveness guidelines published
November 15, 2010Sales and Marketing Dr Mairin Ryan, Economic Evaluation of Health Technologies, HIQA, Health Information and Quality Authority, IPHA, Ireland, Irish Pharmaceutical Healthcare Association, NICE, hta
The Irish government has published new health technology assessment guidelines to help decision-makers estimate the cost-effectiveness of medical treatments. The …
AstraZeneca staff strike as pension talks breakdown
November 15, 2010Manufacturing and Production AZ, AstraZeneca, AstraZeneca UK Manufacturing, GMB, Hurdsfield Industrial Estate, pensions, strikes, unions
Workers at an AstraZeneca facility in the UK went back on strike for the eighth time last week after talks …
Tylenol recall warrants thorough, public investigation, says ISMP
November 15, 2010Manufacturing and Production FDA, ISMP, Institute for Safe Medication Practices, Johnson & Jonson, MedWatch, Tylenol, Tylenol recall
Johnson & Jonson’s recall of Tylenol painkiller products was one of the key safety trends identified in the last quarter …
Sam Barnes joins Axon Communications
November 12, 2010Medical Communications AXON Communications, Joss Lyons-White, Sam Barnes, appointment, medical communications
Surrey, UK-based agency Axon Communications has appointed Sam Barnes director of PR. Sam has over 15 years of experience in healthcare …
Digital Pharma: Pfizer and Boehringer’s online COPD awareness
November 12, 2010Medical Communications Boehringer Ingelheim, COPD, Digital Pharma blog, Managing COPD, NICE, Pfizer, Spiriva, chronic obstructive pulmonary disease
Pfizer and Boehringer Ingelheim have launched an online campaign to publicise the latest NICE guidelines on COPD to healthcare professionals …
Bavarian Nordic courting cancer vaccine backers
November 12, 2010Research and Development, Sales and Marketing Bavarian Nordic, Dendreon, Prostvac, Provenge, TroVax, cancer vaccine, prostate cancer, prostate cancer vaccine, zibotentan
Danish biotech Bavarian Nordic is in ‘advanced discussions’ with a number of potential pharma partners for its phase II therapeutic …
FDA approves Merck’s HIV fat drug Egrifta
November 12, 2010Research and Development, Sales and Marketing EMD Serono, Egrifta, FDA, HIV, Merck KGaA, abdominal fat in HIV, tesamorelin
US regulatory authorities have approved the first treatment indicated to target abdominal fat in patients with HIV after trials showed …
Germany to cut drug prices by 2 billion euro
November 12, 2010Sales and Marketing Cornelia Yzer, GKV-Spitzenverband, Germany, IQWIG, Philipp Rosler, VFA, health insurers, healthcare spending, innovative medicines
The lower house of the German Parliament has passed a new law to control the cost of new prescription medicines. …
NICE stands firm on Avastin rejection
November 12, 2010Sales and Marketing NICE, Roche, avastin, bevacizumab, colon cancer, metastatic colorectal cancer, patient access scheme
NICE has refused to recommend Roche’s blockbuster cancer drug Avastin for the treatment of metastatic colorectal cancer in its final …
ABPI appoints communications director
November 11, 2010Research and Development, Sales and Marketing ABPI, Amanda Callaghan, Royal College of Nursing, appointment, research and development, sales and marketing
UK industry body the ABPI has appointed Amanda Callaghan director of corporate communications. She starts the role on 31 January …
Latest content
Migraine annual economic and quality-of-life burden in UK
bit.bio expands human heart cell portfolio through myriamed partnership
Phoenix Labs acquires Kent Pharma
Astoriom acquires Sampled’s UK stability storage operations
